Kewaunee Scientific Corporation (NASDAQ: KEQU) announced its second quarter results for fiscal year 2026 with significant increases in sales.
The company reported a 46.8% increase in sales compared to the prior year's second quarter, reaching $70,096,000.
Despite a decrease in pre-tax earnings, Kewaunee Scientific maintained strong performance in its Domestic and International segments.
Sales Increase
Sales for the second quarter of fiscal year 2026 grew by 46.8% compared to the prior year.
Order Backlog
The Company's order backlog was $192.9 million on October 31, 2025, showing steady growth compared to previous periods.
Segment Performance
Domestic and International segments both showed growth in sales and earnings, offsetting the Corporate segment's losses.
- Kewaunee Scientific's performance in the second quarter reflects a strong demand for its products and services, particularly in the Domestic and International segments.
- The company's strategic investments in expanding its Corporate platform are aimed at supporting future growth and maintaining a competitive edge in the market.
Kewaunee Scientific Corporation's second quarter results demonstrate a robust sales performance and strategic investments for future growth. Despite challenges in certain segments, the company's overall financial position remains stable and poised for continued success in the upcoming quarters.